Below are the most recent publications written about "Medication Adherence" by people in Profiles.
-
Kiene SM, Miller AP, Ediau M, Tuhebwe D, Sileo KM, Naigino R, Hahn JA, Reed E, Anecho A, Mukasa B, Lin CD, Wanyenze RK, Tumwesigye NM. A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high-risk alcohol use and improve antiretroviral therapy adherence for men in Uganda. Addiction. 2026 Jan; 121(1):94-107.
-
Nawfal ES, Gray A, Ladner R, Li T, Sheehan DM, Fennie K, Jean-Gilles M, Ward MK, Fernandez SB, Beach MC, D?vieux JG, Trepka MJ. Race- and ethnicity-specific patient-provider relationship characteristics associated with antiretroviral therapy adherence and viral suppression among minority women with HIV, Miami-Dade County, Florida, 2021-2022. AIDS Care. 2025 Nov; 37(11):1843-1856.
-
Asfar T, Lee DJ, Alcaide ML, Jones DL, Zvolensky MJ, Oluwole OJ, Pan Y, Brewer J, Carrico A. A Proof-of-Concept Feasibility Trial Testing a Multi-Component App-Based Intervention for Improving Smoking Cessation and Adherence to Treatment in Low-Income HIV Patients. Nicotine Tob Res. 2025 Aug 22; 27(9):1513-1523.
-
Sheehan DM, Ram?rez-Ortiz D, Gwanzura T, Lewis PS, Ertl MM, Duncan DT, Swendeman D, Mu?oz-Laboy M, Devieux JG, Trepka MJ. Daily Factors Associated with Antiretroviral Therapy Adherence Among Young Latino Sexual Minority Men with HIV: A 28-Day Daily Diary Study. AIDS Behav. 2025 Oct; 29(10):3054-3069.
-
Omole TD, Mrkva A, Ferry D, Shepherd E, Caratelli J, Davis N, Akatue R, Bickmore T, Paasche-Orlow MK, Magnani JW. Augmenting Engagement in Decentralized Clinical Trials for Atrial Fibrillation: Development and Implementation of a Programmatic Architecture. JMIR Cardio. 2025 May 12; 9:e66436.
-
Nawfal ES, Sheehan DM, Iba?ez GE, Hayes T, Gray A, Trepka MJ. Modeling the Mediating Effects of HIV-Related Stigma on the Associations Between Race/Ethnicity and Antiretroviral Therapy Adherence and Viral Suppression Among Diverse Racial and Ethnic Minority Women with HIV. AIDS Behav. 2025 Aug; 29(8):2530-2541.
-
Diaby V, Pandey S, Sanogo V, Dhayan Almutairi R, Kanoria Y, Nag SS. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with schizophrenia in the United States. J Manag Care Spec Pharm. 2025 Jan; 31(1):53-59.
-
Diaby V, Pandey S, Sanogo V, Almutairi RD, Kanoria Y, Nag SS. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with bipolar I disorder in the United States. J Manag Care Spec Pharm. 2025 Jan; 31(1):60-67.
-
Davis-Ewart L, Atkins L, Ghanooni D, Diaz JE, Chuku CC, Balise R, DeVries BA, Miller-Perusse M, Ackley Iii D, Moskowitz JT, McCollister K, Fardone E, Hirshfield S, Horvath KJ, Carrico AW. Supporting treatment adherence for resilience and thriving (START): protocol for a mHealth randomized controlled trial. BMC Public Health. 2024 08 29; 24(1):2350.
-
Diaz JE, Ghanooni D, Atkins L, Sam SS, Kantor R, Miller-Perusse M, Chuku CC, Valentin O, Balise RR, Davis-Ewart L, Tisler A, Horvath KJ, Carrico AW, Hirshfield S. Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants. AIDS Behav. 2024 Nov; 28(11):3809-3818.